
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
caspase-7 CRISPR/Cas9 KO Plasmid (m) | sc-419468 | 20 µg | $397.00 |
Mouse Casp7 encodes caspase-7, an executioner cysteine-aspartate protease that is activated downstream of initiator caspases during intrinsic and extrinsic apoptosis. Once processed, caspase-7 cleaves multiple cellular substrates to drive characteristic apoptotic morphology and contributes to regulated cell death programs linked to mitochondrial signaling, death receptor pathways, and proteostasis stress. Caspase-7 activity interfaces with inflammatory and immune signaling through crosstalk with caspase networks and can influence tissue remodeling and responses to cytotoxic stress. Dysregulated apoptosis involving CASP7 has been implicated in phenotypes relevant to cancer biology, neurodegeneration, and immune-mediated pathology, making Casp7 a useful node for mechanistic studies of cell fate control.
caspase-7 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Casp7 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Casp7 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Casp7 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish caspase-7 protein expression.
This CRISPR knockout system enables efficient generation of Casp7-deficient cell models for investigation of caspase-7 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.